Report Detail
Global Vinpocetine Market Insights, Forecast to 2025
- RnM2453806 |
- 27 April, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis
The global Vinpocetine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Vinpocetine market based on company, product type, end user and key regions.
This report studies the global market size of Vinpocetine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Vinpocetine in these regions.
This research report categorizes the global Vinpocetine market by top players/brands, region, type and end user. This report also studies the global Vinpocetine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Gedeon Richter
Runhong
Sun Pharma
WZT
PUDE
Welman
ZhiTong
Liaoning Zhiying
COVEX
Northeast Pharma
Micro Labs
Market size by Product
Tablet
Injection
Market size by End User
Household
Hospital
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Vinpocetine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Vinpocetine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Vinpocetine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Vinpocetine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Vinpocetine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Vinpocetine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Vinpocetine Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Vinpocetine Market Size Growth Rate by Product
- 1.4.2 Tablet
- 1.4.3 Injection
- 1.5 Market by End User
- 1.5.1 Global Vinpocetine Market Size Growth Rate by End User
- 1.5.2 Household
- 1.5.3 Hospital
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Vinpocetine Market Size
- 2.1.1 Global Vinpocetine Revenue 2014-2025
- 2.1.2 Global Vinpocetine Sales 2014-2025
- 2.2 Vinpocetine Growth Rate by Regions
- 2.2.1 Global Vinpocetine Sales by Regions
- 2.2.2 Global Vinpocetine Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Vinpocetine Sales by Manufacturers
- 3.1.1 Vinpocetine Sales by Manufacturers
- 3.1.2 Vinpocetine Sales Market Share by Manufacturers
- 3.1.3 Global Vinpocetine Market Concentration Ratio (CR5 and HHI)
- 3.2 Vinpocetine Revenue by Manufacturers
- 3.2.1 Vinpocetine Revenue by Manufacturers (2014-2019)
- 3.2.2 Vinpocetine Revenue Share by Manufacturers (2014-2019)
- 3.3 Vinpocetine Price by Manufacturers
- 3.4 Vinpocetine Manufacturing Base Distribution, Product Types
- 3.4.1 Vinpocetine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Vinpocetine Product Type
- 3.4.3 Date of International Manufacturers Enter into Vinpocetine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Vinpocetine Sales by Product
- 4.2 Global Vinpocetine Revenue by Product
- 4.3 Vinpocetine Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Vinpocetine Breakdown Data by End User
6 North America
- 6.1 North America Vinpocetine by Countries
- 6.1.1 North America Vinpocetine Sales by Countries
- 6.1.2 North America Vinpocetine Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Vinpocetine by Product
- 6.3 North America Vinpocetine by End User
7 Europe
- 7.1 Europe Vinpocetine by Countries
- 7.1.1 Europe Vinpocetine Sales by Countries
- 7.1.2 Europe Vinpocetine Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Vinpocetine by Product
- 7.3 Europe Vinpocetine by End User
8 Asia Pacific
- 8.1 Asia Pacific Vinpocetine by Countries
- 8.1.1 Asia Pacific Vinpocetine Sales by Countries
- 8.1.2 Asia Pacific Vinpocetine Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Vinpocetine by Product
- 8.3 Asia Pacific Vinpocetine by End User
9 Central & South America
- 9.1 Central & South America Vinpocetine by Countries
- 9.1.1 Central & South America Vinpocetine Sales by Countries
- 9.1.2 Central & South America Vinpocetine Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Vinpocetine by Product
- 9.3 Central & South America Vinpocetine by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Vinpocetine by Countries
- 10.1.1 Middle East and Africa Vinpocetine Sales by Countries
- 10.1.2 Middle East and Africa Vinpocetine Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Vinpocetine by Product
- 10.3 Middle East and Africa Vinpocetine by End User
11 Company Profiles
- 11.1 Gedeon Richter
- 11.1.1 Gedeon Richter Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Gedeon Richter Vinpocetine Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Gedeon Richter Vinpocetine Products Offered
- 11.1.5 Gedeon Richter Recent Development
- 11.2 Runhong
- 11.2.1 Runhong Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Runhong Vinpocetine Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Runhong Vinpocetine Products Offered
- 11.2.5 Runhong Recent Development
- 11.3 Sun Pharma
- 11.3.1 Sun Pharma Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Sun Pharma Vinpocetine Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Sun Pharma Vinpocetine Products Offered
- 11.3.5 Sun Pharma Recent Development
- 11.4 WZT
- 11.4.1 WZT Company Details
- 11.4.2 Company Business Overview
- 11.4.3 WZT Vinpocetine Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 WZT Vinpocetine Products Offered
- 11.4.5 WZT Recent Development
- 11.5 PUDE
- 11.5.1 PUDE Company Details
- 11.5.2 Company Business Overview
- 11.5.3 PUDE Vinpocetine Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 PUDE Vinpocetine Products Offered
- 11.5.5 PUDE Recent Development
- 11.6 Welman
- 11.6.1 Welman Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Welman Vinpocetine Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Welman Vinpocetine Products Offered
- 11.6.5 Welman Recent Development
- 11.7 ZhiTong
- 11.7.1 ZhiTong Company Details
- 11.7.2 Company Business Overview
- 11.7.3 ZhiTong Vinpocetine Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 ZhiTong Vinpocetine Products Offered
- 11.7.5 ZhiTong Recent Development
- 11.8 Liaoning Zhiying
- 11.8.1 Liaoning Zhiying Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Liaoning Zhiying Vinpocetine Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Liaoning Zhiying Vinpocetine Products Offered
- 11.8.5 Liaoning Zhiying Recent Development
- 11.9 COVEX
- 11.9.1 COVEX Company Details
- 11.9.2 Company Business Overview
- 11.9.3 COVEX Vinpocetine Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 COVEX Vinpocetine Products Offered
- 11.9.5 COVEX Recent Development
- 11.10 Northeast Pharma
- 11.10.1 Northeast Pharma Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Northeast Pharma Vinpocetine Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Northeast Pharma Vinpocetine Products Offered
- 11.10.5 Northeast Pharma Recent Development
- 11.11 Micro Labs
12 Future Forecast
- 12.1 Vinpocetine Market Forecast by Regions
- 12.1.1 Global Vinpocetine Sales Forecast by Regions 2019-2025
- 12.1.2 Global Vinpocetine Revenue Forecast by Regions 2019-2025
- 12.2 Vinpocetine Market Forecast by Product
- 12.2.1 Global Vinpocetine Sales Forecast by Product 2019-2025
- 12.2.2 Global Vinpocetine Revenue Forecast by Product 2019-2025
- 12.3 Vinpocetine Market Forecast by End User
- 12.4 North America Vinpocetine Forecast
- 12.5 Europe Vinpocetine Forecast
- 12.6 Asia Pacific Vinpocetine Forecast
- 12.7 Central & South America Vinpocetine Forecast
- 12.8 Middle East and Africa Vinpocetine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Vinpocetine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Vinpocetine . Industry analysis & Market Report on Vinpocetine is a syndicated market report, published as Global Vinpocetine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Vinpocetine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
